We studied adverse reactions to immunisation in 541 individuals receiving simultaneous pneumococcal and influenza vaccination, and in 320 recipients of pneumococcal vaccine alone. Five days after immunisation, the participants completed a questionnaire covering systemic and local reactions to vaccination. Adverse effects were rated as mild if they did not interfere with the participant's daily activities, and moderate or serious if they moderately or markedly restricted these activities. There were no differences between the groups regarding general malaise, headache, myalgias and elevated body temperature. Redness at the injection site, but not soreness or swelling, occurred more frequently in individuals immunised simultaneously with both vaccines. Except for fever and local swelling, adverse reactions were significantly more frequent in women than in men in study groups. The rate of adverse reactions was higher in individuals less then 65 years of age than in older participants. Local reactions were reported by 358 (41.6%) participants, but they were mild and soon subsided. No serious reactions were reported. pneumococcal and influenza vaccine can be safely administered simultaneously.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2004.02.003DOI Listing

Publication Analysis

Top Keywords

adverse reactions
12
pneumococcal vaccine
8
influenza vaccine
8
pneumococcal influenza
8
local reactions
8
reactions reported
8
reactions
7
reactions pneumococcal
4
vaccine
4
vaccine combination
4

Similar Publications

This study aimed to assess the efficacy and safety of thioamide as a maintenance therapy for peripheral T-cell lymphoma (PTCL) . This study retrospectively analyzed the data from 58 patients with PTCL who were treated in the Department of Hematology at the First Affiliated Hospital of Nanjing Medical University from January 2015 to July 2022. Chidamide was orally administered as a maintenance therapy after first-line or salvage treatment.

View Article and Find Full Text PDF

N-Acetyl-leucine in progressive CACNA1A ataxia: A case series.

Eur J Paediatr Neurol

January 2025

Department of Pediatric Neurology, University Children's Hospital and Medical Faculty, Justus Liebig University of Giessen, Giessen, Germany.

Background: CACNA1A-related disorders are rare and progressive; to date, there is no approved treatment. Trials with N-acetyl-leucine (NAL) demonstrated efficacy in disorders featuring ataxia, cognitive impairment, and epilepsy. Accordingly, we hypothesized that NAL may be effective in CACNA1A-associated disorders.

View Article and Find Full Text PDF

The risk of developing a severe delayed cutaneous reaction (SCAR) is very low following iodine-based contrast medium (ICM) administration and extremely low following gadolinium-based contrast agent (GBCA) administration. However, SCAR can be very severe and potentially life-threatening. It is crucial for the imaging physician to recognize danger signals: bullous skin eruption, skin erosion and detachment, mucosal involvement, systemic symptoms, and laboratory abnormalities.

View Article and Find Full Text PDF

Purpose: To develop an educational, interactive, ultra-high resolution, in vivo magnetic resonance (MR) neurography atlas for direct visualization of the brachial plexus and upper extremity.

Methods: A total of 16 adult volunteers without known peripheral neuropathy underwent magnetic resonance (MR) neurography of the brachial plexus and upper extremity. To improve vascular suppression, subjects received an intravenous infusion of ferumoxytol.

View Article and Find Full Text PDF

Integrated removal of chromium, lead, and cadmium using nano-zero-valent iron-supported biochar: Mechanistic insights and eco-toxicity assessment.

Ecotoxicol Environ Saf

January 2025

College of Resources and Environmental Sciences, Gansu Agricultural University, Lanzhou 730070, PR China; Gansu Provincial Key Laboratory of Arid land Crop Science, Gansu Agricultural University, Lanzhou 730070, PR China. Electronic address:

The contamination of water and soil by heavy metals (HMs) is a global issue that should be given much more concern. Modified nano-zero-valent iron (nZVI) composites offer an effective strategy for HMs remediation, but few studies have focused on removing coexisting HMs and the eco-toxicity of the composite. In this study, corn straw biochar-supported nZVI composites (nZVI-BC) were synthesized, characterized and used for the removal of Cr, Pb, and Cd in single and multi-system at different composites dosages, metal concentrations, and solution pH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!